Effects of Smartphone Application-Based Integrated Self-Care Support System for Hypertensive Patients

Not Applicable

• Conditions: Hypertension

• Registration Number: JPRN-UMIN000035898
• Lead Sponsor: Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-02-18
• Study Completion: 2023-03-25
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 360

Inclusion Criteria

Not provided

Exclusion Criteria

1.A patient who cannot use smartphone application 2.A patient diagonized as secondary hypertension 3.A patient with chronic atrial fibrillation 4.A patient with severe renal failure (eGFR<15mL/min/1.73m2) or a dialysis patient 5.A patient who has a history of major cardiovascular events within the past 3 months 6.A patient whose antihypertensive medication was changed within the past 1 month 7.A patient who has a plan of hospitalization due to surgery or examination at the time of study participation 8.A patient who is using another smartphone application for hypertension at the time of study participation 9.A patients who is judged as inappropriate for the study participation by the principal investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in systolic blood pressure from baseline to 12 months

Secondary Outcome Measures

Name	Time	Method
1.Change in systolic blood pressure from baseline to 6 months 2.Change in diastolic blood pressure from baseline to each follow-up point (6 months and 12 months) 3.Change in frequency of blood pressure measurements at home from baseline to each follow-up point (6 months and 12 months) 4.Systolic blood pressure 5.Diastolic blood pressure 6.Frequency of blood pressure measurements at home 7.Quality of life (EQ-5D-5L) 8.Self-efficacy (GSES) 9.Medication-taking adherence (MMAS-4) 10.Medical cost 11.Adverse events 12.Change in number or dosage of antihypertensive medicine 13.Days until change of antihypertensive medicine after the start of clinical study 14.Self-monitoring data 15.Frequency of use of smartphone application